MEGIN
  • About us
  • MEG Maps™
    • MEG Maps™
    • Book a MEG Maps™ Demo
  • Insights & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts & Studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Contact us
    • Contact us
    • Book a MEG Maps™ Demo
    • MEGIN Community
  • 🇨🇳
Select Page
Hiroshima University announces the sale of the first TRIUX™ neo in Japan

Hiroshima University announces the sale of the first TRIUX™ neo in Japan

by MEGIN | Jul 3, 2023 | MEGIN News

Hiroshima University Hospital press release – an announcement from our customer-partner   Hiroshima University Hospital established its Epilepsy Center in January 2014. The Epilepsy Center has since been responsible for providing tertiary medical care as part of the...
Fixel Institute expands care with new neuroimaging and clinical research suites

Fixel Institute expands care with new neuroimaging and clinical research suites

by MEGIN | Apr 27, 2023 | MEGIN News

A 15,000-square-foot neuroimaging suite that includes four high-tech imaging machines — including one of just three in the Southeast — opened Monday as the Norman Fixel Institute for Neurological Diseases at UF Health moves into a new phase of its growth. In addition...
MEGIN’s latest global customer survey finds customers are extremely satisfied with the customer service, project management and installation offered by MEGIN

MEGIN’s latest global customer survey finds customers are extremely satisfied with the customer service, project management and installation offered by MEGIN

by MEGIN | Mar 1, 2023 | MEGIN News

Earlier this year, as part of its commitment to continually improving its customer service, MEGIN partnered with B2B international – a full-service market research company, to issue a global satisfaction survey to its customers, looking closely at the service MEGIN...
Bridging the gap: Adopting innovative technology in UK clinical settings

Bridging the gap: Adopting innovative technology in UK clinical settings

by MEGIN | Jan 30, 2023 | Epilepsy, MEGIN News

The role of Magnetoencephalography (MEG) technology, its clinical use in the UK, and a vision for the future. Stefano Seri, emeritus professor of clinical neurophysiology at the IHN (pictured below), said the technology could help to support thousands of patients in...
Advanced Imaging in Epilepsy: How MEG Can Assist in Surgery

Advanced Imaging in Epilepsy: How MEG Can Assist in Surgery

by MEGIN | Oct 6, 2022 | Epilepsy, MEGIN News

In this webinar, viewers will learn how MEG is a key part of the epilepsy surgery evaluation, including information about the basics and safety of a MEG study, and hear about how MEG can help the surgeon by mapping key functions (speech, motor, and vision) onto their...
MEGIN joins over 30 UK HealthTech pioneers on ABHI mission to bolster trade ties in California

MEGIN joins over 30 UK HealthTech pioneers on ABHI mission to bolster trade ties in California

by MEGIN | Sep 14, 2022 | MEGIN News

MEGIN is delighted to be among the delegates of leading UK innovators heading to California this week (12-16 September 2022) as part of ABHI’s mission to bolster trade partnerships and promote the strengths of UK HealthTech stateside. The visit builds on the successes...
« Older Entries
Next Entries »

Home
About us

MEG Maps™
Careers
Contact us
Join Our Mailing List

Insights & education
News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

MEGIN Community

Patients

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2025© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.

Subscribe to MEGIN Matters

Don’t miss the latest MEG insights and MEGIN news – complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!